Table 5.
Interval cancer diagnosed between the first and second screening rounds after a negative screen, by type of HPV detection target. Includes women with a negative screening test in the English HPV screening pilot’s first round in 2013-16, with information on cervical cancer available until the end of 2018
| After a negative screen for HPV | APTIMA | RealTime | cobas | RealTime or cobas combined | APTIMA v cobas (hazard ratio (95% CI)) | RealTime v cobas (hazard ratio (95% CI)) | APTIMA v RealTime (hazard ratio (95% CI)) | APTIMA v RealTime or cobas combined (hazard ratio (95% CI)) | 
|---|---|---|---|---|---|---|---|---|
| Total No of woman years | 143 049 | 483 578 | 385 193 | 868 771 | — | — | — | — | 
| Total No of cervical cancers diagnosed (No of cervical cancers diagnosed per 100 000 woman years) | 1 (0.70) | 4 (0.83) | 8 (2.08) | 12 (1.38) | 0.35 (0.04 to 2.84)* | 0.40 (0.12 to 1.33)* | 0.73 (0.08 to 6.21)* | 0.51 (0.07 to 3.91)* | 
CI=confidence interval; HPV=high risk human papillomavirus.
Unadjusted estimate owing to a small number of cases.